JUN and neoplasm: The potency of 2xAARE-YB-CAR-Jun-T cells is likely attributable to a substantial increase in the number of tumor-infiltrating activated CAR-T cells, as evidenced by elevated expression of the activation marker CD69 (Fig. 7D and Supplementary Fig. 8B).